Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and feasibility of intranasal ketamine on acute suicidality
2020-002905-24Phase 2Active
- Sponsor
- University Medical Center Groningen
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in suicidal ideation, suicidal crisis (SCS) and mental disorder comparing Intranasal ketamine with Placebo intranasal spray (2 arms). Primary endpoint: Change in suicidality scores on BSSI between baseline and 180 minutes. Started Jun 2021; status: active.
02
Drugs
ketamine
03
Conditions
suicidal ideationsuicidal crisis (SCS)mental disorder
Beyond the preview
Go deeper on 2020-002905-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-002905-24.